1. The FDA approved the first interoperable insulin pump, Tandem Diabetes Care t:Slim X2 insulin pump, for delivering insulin for children and adults with diabetes.
2. Egaten is the first treatment to treat fascioliasis, a rare tropical disease also called liver fluke infestation. The disease is caused by two species of parasitic flatworms that infect people after they consume its larvae in contaminated water.
3. The FDA approved a split-dosing regimen for Darzalex, a multiple myeloma treatment. The new approval allows patients to split the infusion over two consecutive days.
4. Cablivi is a injection for the treatment of acquired thrombotic thrombocytopenic purpura, a rare blood disorder.
More articles on supply chain:
Facebook to help connect hospitals to blood donors
FDA commissioner suggests blockchain technology to improve drug traceability
An injection for a blood clotting disorder, a rival Botox treatment & more: 4 recent FDA approvals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.